Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

TJ Revett, GB Baker, J Jhamandas, S Kar - Journal of Psychiatry and …, 2013 - jpn.ca
Alzheimer disease is the most prevalent form of dementia globally and is characterized
premortem by a gradual memory loss and deterioration of higher cognitive functions and …

Friend or foe? Defining the role of glutamate in aging and Alzheimer's disease

MKF Cox, ER Hascup, A Bartke, KN Hascup - Frontiers in aging, 2022 - frontiersin.org
Aging is a naturally occurring decline of physiological processes and biological pathways
that affects both the structural and functional integrity of the body and brain. These …

Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs isogenic controls

S Ghatak, N Dolatabadi, D Trudler, XT Zhang, Y Wu… - elife, 2019 - elifesciences.org
Human Alzheimer's disease (AD) brains and transgenic AD mouse models manifest
hyperexcitability. This aberrant electrical activity is caused by synaptic dysfunction that …

Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention

J Marsh, P Alifragis - Neural regeneration research, 2018 - journals.lww.com
The most prevalent form of dementia in the elderly is Alzheimer's disease. A significant
contributing factor to the progression of the disease appears to be the progressive …

Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease

K Takahashi, JB Foster, CLG Lin - Cellular and Molecular Life Sciences, 2015 - Springer
Glutamate is the predominant excitatory neurotransmitter in the central nervous system.
Excitatory amino acid transporter 2 (EAAT2) is primarily responsible for clearance of …

Amyloid beta-related alterations to glutamate signaling dynamics during Alzheimer's disease progression

CA Findley, A Bartke, KN Hascup, ER Hascup - ASN neuro, 2019 - journals.sagepub.com
Alzheimer's disease (AD) ranks sixth on the Centers for Disease Control and Prevention Top
10 Leading Causes of Death list for 2016, and the Alzheimer's Association attributes 60% to …

Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease

P Padmanabhan, A Kneynsberg, J Götz - Nature Reviews …, 2021 - nature.com
The synapse has emerged as a critical neuronal structure in the degenerative process of
Alzheimer disease (AD), in which the pathogenic signals of two key players—amyloid-β (Aβ) …

[HTML][HTML] Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

MC De Wilde, CR Overk, JW Sijben, E Masliah - Alzheimer's & dementia, 2016 - Elsevier
Introduction Loss of synapses best correlates to cognitive deficits in Alzheimer's disease
(AD) in which oligomeric neurotoxic species of amyloid-β appears to contribute synaptic …

Human brain-derived Aβ oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP

Z Wang, RJ Jackson, W Hong, WM Taylor… - Journal of …, 2017 - jneurosci.org
Compelling genetic evidence links the amyloid precursor protein (APP) to Alzheimer's
disease (AD) and several theories have been advanced to explain the relationship. A …

Sex differences in psychiatric disease: a focus on the glutamate system

MM Wickens, DA Bangasser, LA Briand - Frontiers in molecular …, 2018 - frontiersin.org
Alterations in glutamate, the primary excitatory neurotransmitter in the brain, are implicated
in several psychiatric diseases. Many of these psychiatric diseases display epidemiological …